Xiaolin Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Xiaolin Yang has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Yongqun He
Unit for Laboratory Animal Medicine, University of Michigan Medical School, Ann Arbor, MI 48109, USA
4 shared publications Keyu Yao
Institute of Information On Traditional Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing, China
2 shared publicationsSuyuan Peng
Institute of Information on Traditional Chinese Medicine, China Academy of Chinese Medical Sciences , Beijing
2 shared publicationsWei Zhou
National Population Health Data Center, Beijing 100005, China
2 shared publicationsWenjia Zhang
Department of Biomedical Engineering, Institute of Basic Medical Sciences Chinese Academy of Medical Sciences, School of Basic Medicine Peking Union Medical College , Beijing 100005
2 shared publicationsYan Zhu
Institute of Information on Traditional Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China
2 shared publications
Latest Publications
- 28 September 2025
- p. 1-9
AI-Ready Competency Framework for Biomedical Scientific Data Literacy.
With the rise of data-intensive research, data literacy has become a critical capability for improving scientific data quality and achieving artificial intelligence (AI) readiness. In the biomedical domain, data are characterized by high complexity and privacy sensitivity, calling for robust and systematic data management skills. This paper reviews current trends in scientific data governance and the evolving policy landscape, highlighting persistent challenges such as inconsistent standards, semantic misalignment, and limited awareness of compliance. These issues are largely rooted in the lack of structured training and practical support for researchers. In response, this study builds on existing data literacy frameworks and integrates the specific demands of biomedical research to propose a comprehensive, lifecycle-oriented data literacy competency model with an emphasis on ethics and regulatory awareness. Furthermore, it outlines a tiered training strategy tailored to different research stages-undergraduate, graduate, and professional, offering theoretical foundations and practical pathways for universities and research institutions to advance data literacy education.
- 28 September 2025
- p. 1-9
AI-Ready Competency Framework for Biomedical Scientific Data Literacy.
With the rise of data-intensive research, data literacy has become a critical capability for improving scientific data quality and achieving artificial intelligence (AI) readiness. In the biomedical domain, data are characterized by high complexity and privacy sensitivity, calling for robust and systematic data management skills. This paper reviews current trends in scientific data governance and the evolving policy landscape, highlighting persistent challenges such as inconsistent standards, semantic misalignment, and limited awareness of compliance. These issues are largely rooted in the lack of structured training and practical support for researchers. In response, this study builds on existing data literacy frameworks and integrates the specific demands of biomedical research to propose a comprehensive, lifecycle-oriented data literacy competency model with an emphasis on ethics and regulatory awareness. Furthermore, it outlines a tiered training strategy tailored to different research stages-undergraduate, graduate, and professional, offering theoretical foundations and practical pathways for universities and research institutions to advance data literacy education.
- Top Cited PapersOpen Access
- 13 March 2025
- Published by Springer Nature in Scientific Data
- Vol. 12 (1) , 1-10
TCMEval-SDT: a benchmark dataset for syndrome differentiation thought of traditional Chinese medicine
This paper presents a large publicly available benchmark dataset (TCMEval-SDT) for the thought process involved in syndrome differentiation in traditional Chinese medicine (TCM). The dataset consists of 300 TCM syndrome diagnosis cases sourced from the internet, classical Chinese medical texts, and medical records from hospitals, with metadata adhering to the Findable, Accessible, Interoperable, and Reusable (FAIR) principles. Each case has been annotated and curated by TCM experts and includes medical record ID, clinical data, explanatory summary, TCM syndrome, clinical information, and TCM pathogenesis, to support algorithms or models in emulating the diagnostic process of TCM clinicians. To provide a comprehensive description of the TCM syndrome diagnosis process, we summarize the diagnosis into four steps: (1) clinical information extraction, (2) TCM pathogenesis reasoning, (3) TCM syndrome reasoning, and (4) explanatory summary. We have also established validation criteria to evaluate their ability in TCM clinical diagnosis using this dataset. To facilitate research and evaluation in syndrome diagnosis of TCM, the TCMEval-SDT dataset is made publicly available under the CC-BY 4.0 license.
- 13 March 2025
- Published by Springer Nature in Scientific Data
- Vol. 12 (1) , 1-10
Top Cited PapersOpen AccessTCMEval-SDT: a benchmark dataset for syndrome differentiation thought of traditional Chinese medicine
This paper presents a large publicly available benchmark dataset (TCMEval-SDT) for the thought process involved in syndrome differentiation in traditional Chinese medicine (TCM). The dataset consists of 300 TCM syndrome diagnosis cases sourced from the internet, classical Chinese medical texts, and medical records from hospitals, with metadata adhering to the Findable, Accessible, Interoperable, and Reusable (FAIR) principles. Each case has been annotated and curated by TCM experts and includes medical record ID, clinical data, explanatory summary, TCM syndrome, clinical information, and TCM pathogenesis, to support algorithms or models in emulating the diagnostic process of TCM clinicians. To provide a comprehensive description of the TCM syndrome diagnosis process, we summarize the diagnosis into four steps: (1) clinical information extraction, (2) TCM pathogenesis reasoning, (3) TCM syndrome reasoning, and (4) explanatory summary. We have also established validation criteria to evaluate their ability in TCM clinical diagnosis using this dataset. To facilitate research and evaluation in syndrome diagnosis of TCM, the TCMEval-SDT dataset is made publicly available under the CC-BY 4.0 license.
- Open Access
- 28 September 2024
- Published by Oxford University Press (OUP) in NAR Genomics and Bioinformatics
- Vol. 6 (4) , lqae157
CancerPro: deciphering the pan-cancer prognostic landscape through combinatorial enrichment analysis and knowledge network insights
Gene expression levels serve as valuable markers for assessing prognosis in cancer patients. To understand the mechanisms underlying prognosis and explore potential therapeutics across diverse cancers, we developed CancerPro (https:/medcode.link/cancerpro). This knowledge network platform integrates comprehensive biomedical data on genes, drugs, diseases and pathways, along with their interactions. By integrating ontology and knowledge graph technologies, CancerPro offers a user-friendly interface for analyzing pan-cancer prognostic markers and exploring genes or drugs of interest. CancerPro implements three core functions: gene set enrichment analysis based on multiple annotations; in-depth drug analysis; and in-depth gene list analysis. Using CancerPro, we categorized genes and cancers into distinct groups and utilized network analysis to identify key biological pathways associated with unfavorable prognostic genes. The platform further pinpoints potential drug targets and explores potential links between prognostic markers and patient characteristics such as glutathione levels and obesity. For renal and prostate cancer, CancerPro identified risk genes linked to immune deficiency pathways and alternative splicing abnormalities. This research highlights CancerPro's potential as a valuable tool for researchers to explore pan-cancer prognostic markers and uncover novel therapeutic avenues. Its flexible tools support a wide range of biological investigations, making it a versatile asset in cancer research and beyond.
- 28 September 2024
- Published by Oxford University Press (OUP) in NAR Genomics and Bioinformatics
- Vol. 6 (4) , lqae157
Open AccessCancerPro: deciphering the pan-cancer prognostic landscape through combinatorial enrichment analysis and knowledge network insights
Gene expression levels serve as valuable markers for assessing prognosis in cancer patients. To understand the mechanisms underlying prognosis and explore potential therapeutics across diverse cancers, we developed CancerPro (https:/medcode.link/cancerpro). This knowledge network platform integrates comprehensive biomedical data on genes, drugs, diseases and pathways, along with their interactions. By integrating ontology and knowledge graph technologies, CancerPro offers a user-friendly interface for analyzing pan-cancer prognostic markers and exploring genes or drugs of interest. CancerPro implements three core functions: gene set enrichment analysis based on multiple annotations; in-depth drug analysis; and in-depth gene list analysis. Using CancerPro, we categorized genes and cancers into distinct groups and utilized network analysis to identify key biological pathways associated with unfavorable prognostic genes. The platform further pinpoints potential drug targets and explores potential links between prognostic markers and patient characteristics such as glutathione levels and obesity. For renal and prostate cancer, CancerPro identified risk genes linked to immune deficiency pathways and alternative splicing abnormalities. This research highlights CancerPro's potential as a valuable tool for researchers to explore pan-cancer prognostic markers and uncover novel therapeutic avenues. Its flexible tools support a wide range of biological investigations, making it a versatile asset in cancer research and beyond.
- 21 May 2024
- Published by Elsevier in Clinica Chimica Acta
- Vol. 560, 119734
Metabolomic biomarkers for benign conditions and malignant ovarian cancer: Advancing early diagnosis
- 21 May 2024
- Published by Elsevier in Clinica Chimica Acta
- Vol. 560, 119734
Metabolomic biomarkers for benign conditions and malignant ovarian cancer: Advancing early diagnosis
- Open Access
- 30 September 2022
- Published by Chinese Medical Sciences Journal in Chinese Medical Sciences Journal
- Vol. 37 (3) , 228-233
Traditional Chinese Medicine (TCM) Domain Ontology: Current Status and Rethinking for the Future Development
The past twenty years have seen the increasingly important role of ontology in traditional Chinese medicine (TCM). However, the development of TCM ontology faces many challenges. Since the epistemologies dramatically differ between TCM and contemporary biomedicine, it is hard to apply the existing top-level ontology mechanically. "Data silos" are widely present in the currently available terminology standards, term sets, and ontologies. The formal representation of ontology needs to be further improved in TCM. Therefore, we propose a unified basic semantic framework of TCM based on in-depth theoretical research on the existing top-level ontology and a re-study of important concepts in TCM. Under such a framework, ontologies in TCM sub-domains should be built collaboratively and be represented formally in a common format. Besides, extensive cooperation should be encouraged by establishing ontology research communities to promote ontology peer review and reuse.
- 30 September 2022
- Published by Chinese Medical Sciences Journal in Chinese Medical Sciences Journal
- Vol. 37 (3) , 228-233
Open AccessTraditional Chinese Medicine (TCM) Domain Ontology: Current Status and Rethinking for the Future Development
The past twenty years have seen the increasingly important role of ontology in traditional Chinese medicine (TCM). However, the development of TCM ontology faces many challenges. Since the epistemologies dramatically differ between TCM and contemporary biomedicine, it is hard to apply the existing top-level ontology mechanically. "Data silos" are widely present in the currently available terminology standards, term sets, and ontologies. The formal representation of ontology needs to be further improved in TCM. Therefore, we propose a unified basic semantic framework of TCM based on in-depth theoretical research on the existing top-level ontology and a re-study of important concepts in TCM. Under such a framework, ontologies in TCM sub-domains should be built collaboratively and be represented formally in a common format. Besides, extensive cooperation should be encouraged by establishing ontology research communities to promote ontology peer review and reuse.
- Open Access
- 24 May 2021
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-11
Integrative web-based analysis of omics data for study of drugs against SARS-CoV-2
Research on drugs against SARS-CoV-2 (cause of COVID-19) has been one of the major world concerns at present. There have been abundant research data and findings in this field. The interference of drugs on gene expression in cell lines, drug-target, protein-virus receptor networks, and immune cell infiltration of the host may provide useful information for anti-SARS-CoV-2 drug research. To simplify the complex bioinformatics analysis and facilitate the evaluation of the latest research data, we developed OmiczViz (http://medcode.link/omicsviz), a web tool that has integrated drug-cell line interference data, virus-host protein–protein interactions, and drug-target interactions. To demonstrate the usages of OmiczViz, we analyzed the gene expression data from cell lines treated with chloroquine and ruxolitinib, the drug-target protein networks of 48 anti-coronavirus drugs and drugs bound with ACE2, and the profiles of immune cell infiltration between different COVID-19 patient groups. Our research shows that chloroquine had a regulatory role of the immune response in renal cell line but not in lung cell line. The anti-coronavirus drug-target network analysis suggested that antihistamine of promethaziney and dietary supplement of Zinc might be beneficial when used jointly with antiviral drugs. The immune infiltration analysis indicated that both the COVID-19 patients admitted to the ICU and the elderly with infection showed immune exhaustion status, yet with different molecular mechanisms. The interactive graphic interface of OmiczViz also makes it easier to analyze newly discovered and user-uploaded data, leading to an in-depth understanding of existing findings and an expansion of existing knowledge of SARS-CoV-2. Collectively, OmicsViz is web program that promotes the research on medical agents against SARS-CoV-2 and supports the evaluation of the latest research findings.
- 24 May 2021
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-11
Open AccessIntegrative web-based analysis of omics data for study of drugs against SARS-CoV-2
Research on drugs against SARS-CoV-2 (cause of COVID-19) has been one of the major world concerns at present. There have been abundant research data and findings in this field. The interference of drugs on gene expression in cell lines, drug-target, protein-virus receptor networks, and immune cell infiltration of the host may provide useful information for anti-SARS-CoV-2 drug research. To simplify the complex bioinformatics analysis and facilitate the evaluation of the latest research data, we developed OmiczViz (http://medcode.link/omicsviz), a web tool that has integrated drug-cell line interference data, virus-host protein–protein interactions, and drug-target interactions. To demonstrate the usages of OmiczViz, we analyzed the gene expression data from cell lines treated with chloroquine and ruxolitinib, the drug-target protein networks of 48 anti-coronavirus drugs and drugs bound with ACE2, and the profiles of immune cell infiltration between different COVID-19 patient groups. Our research shows that chloroquine had a regulatory role of the immune response in renal cell line but not in lung cell line. The anti-coronavirus drug-target network analysis suggested that antihistamine of promethaziney and dietary supplement of Zinc might be beneficial when used jointly with antiviral drugs. The immune infiltration analysis indicated that both the COVID-19 patients admitted to the ICU and the elderly with infection showed immune exhaustion status, yet with different molecular mechanisms. The interactive graphic interface of OmiczViz also makes it easier to analyze newly discovered and user-uploaded data, leading to an in-depth understanding of existing findings and an expansion of existing knowledge of SARS-CoV-2. Collectively, OmicsViz is web program that promotes the research on medical agents against SARS-CoV-2 and supports the evaluation of the latest research findings.
- Open Access
- 22 November 2019
- Published by American Association for the Advancement of Science (AAAS) in Journal of Bio-X Research
- Vol. 02 (04) , 178-184
Biomedical ontologies and their development, management, and applications in and beyond China
Since the boom of biomedical big data studies, various big data processing technologies have been developed rapidly. As an important form of knowledge representation, ontology has become an important means for the utilization and integration of biomedical big data. The emergence of new technologies for ontology development has resulted in the generation of many biomedical ontologies by many ontology development communities. The Open Biological and Biomedical Ontology Foundry, an academic organization for bio-ontology developers, has provided a set of principles to guide community-based open ontology construction. The Open Biological and Biomedical Ontology Foundry have also built many widely used ontologies, such as Gene Ontology, Human Phenotype Ontology, and Chemical Entities of Biological Interest. Other various ontology repositories have also been created and used to support ontology reuse. Many efficient tools for ontology applications, such as data annotation and terms mapping, have also been developed. High quality ontologies are also being used to develop new methods and tools for biomedical data analysis. The applications of Gene Ontology and Human Phenotype Ontology for data analysis and integration in recent years are reviewed here. To promote the development and applications of biomedical ontologies in China, a research community, OntoChina, was founded recently. OntoChina aims to support the development of reference ontologies, especially bilingual and Chinese translated ontologies. OntoChina also encourages ontology developers to follow the Open Biological and Biomedical Ontology Foundry principles.
- 22 November 2019
- Published by American Association for the Advancement of Science (AAAS) in Journal of Bio-X Research
- Vol. 02 (04) , 178-184
Open AccessBiomedical ontologies and their development, management, and applications in and beyond China
Since the boom of biomedical big data studies, various big data processing technologies have been developed rapidly. As an important form of knowledge representation, ontology has become an important means for the utilization and integration of biomedical big data. The emergence of new technologies for ontology development has resulted in the generation of many biomedical ontologies by many ontology development communities. The Open Biological and Biomedical Ontology Foundry, an academic organization for bio-ontology developers, has provided a set of principles to guide community-based open ontology construction. The Open Biological and Biomedical Ontology Foundry have also built many widely used ontologies, such as Gene Ontology, Human Phenotype Ontology, and Chemical Entities of Biological Interest. Other various ontology repositories have also been created and used to support ontology reuse. Many efficient tools for ontology applications, such as data annotation and terms mapping, have also been developed. High quality ontologies are also being used to develop new methods and tools for biomedical data analysis. The applications of Gene Ontology and Human Phenotype Ontology for data analysis and integration in recent years are reviewed here. To promote the development and applications of biomedical ontologies in China, a research community, OntoChina, was founded recently. OntoChina aims to support the development of reference ontologies, especially bilingual and Chinese translated ontologies. OntoChina also encourages ontology developers to follow the Open Biological and Biomedical Ontology Foundry principles.
- Open Access
- 27 October 2019
- Published by Chinese Medical Sciences Journal in Chinese Medical Sciences Journal
- Vol. 34 (4) , 277-280
Ontology: Footstone for Strong Artificial Intelligence
In the past ten years, the application of artificial intelligence (AI) in biomedicine has increased rapidly, which roots in the rapid growth of biomedicine data, the improvement of computing performance, and the development of deep learning methods. At present, there are great difficulties in front of AI for solving complex and comprehensive medical problems. Ontology can play an important role in how to make machines have stronger intelligence and has wider applications in the medical field. By using ontologies, (meta) data can be standardized so that data quality is improved and more data analysis methods can be introduced, data integration can be supported by the semantics relationships which are specified in ontologies, and effective logic expression in nature language can be better understood by machine. This can be a pathway to stronger AI. Under this circumstance, the Chinese Conference on Biomedical Ontology and Terminology was held in Beijing in autumn 2019, with the theme "Making Machine Understand Data". The success of this conference further improves the development of ontology in the field of biomedical information in China, and will promote the integration of Chinese ontology research and application with the international standards and the findability, accessibility, interoperability, and reusability(FAIR) Data Principle.
- 27 October 2019
- Published by Chinese Medical Sciences Journal in Chinese Medical Sciences Journal
- Vol. 34 (4) , 277-280
Open AccessOntology: Footstone for Strong Artificial Intelligence
In the past ten years, the application of artificial intelligence (AI) in biomedicine has increased rapidly, which roots in the rapid growth of biomedicine data, the improvement of computing performance, and the development of deep learning methods. At present, there are great difficulties in front of AI for solving complex and comprehensive medical problems. Ontology can play an important role in how to make machines have stronger intelligence and has wider applications in the medical field. By using ontologies, (meta) data can be standardized so that data quality is improved and more data analysis methods can be introduced, data integration can be supported by the semantics relationships which are specified in ontologies, and effective logic expression in nature language can be better understood by machine. This can be a pathway to stronger AI. Under this circumstance, the Chinese Conference on Biomedical Ontology and Terminology was held in Beijing in autumn 2019, with the theme "Making Machine Understand Data". The success of this conference further improves the development of ontology in the field of biomedical information in China, and will promote the integration of Chinese ontology research and application with the international standards and the findability, accessibility, interoperability, and reusability(FAIR) Data Principle.
- Open Access
- 25 April 2019
- Published by Springer Nature in BMC Bioinformatics
- Vol. 20 (S5) , 249-258
The cell line ontology-based representation, integration and analysis of cell lines used in China
The Chinese National Infrastructure of Cell Line stores and distributes cell lines for biomedical research in China. This study aims to represent and integrate the information of NICR cell lines into the community-based Cell Line Ontology (CLO). We have aligned, represented, and added all identified 2704 cell line cells in NICR to CLO. We also proposed new ontology design patterns to represent the usage of cell line cells as disease models by inducing tumor formation in model organisms, and the relations between cell line cells and their expressed or overexpressed genes or proteins. The resulting CLO-NICR ontology also includes the Chinese representation of the NICR cell line information. CLO-NICR was merged into the general CLO. To serve the cell research community in China, the Chinese version of CLO-NICR was also generated and deposited in the OntoChina ontology repository. The usage of CLO-NICR was demonstrated by DL query and knowledge extraction. In summary, all identified cell lines from NICR are represented by the semantics framework of CLO and incorporated into CLO as a most recent update. We also generated a CLO-NICR and its Chinese view (CLO-NICR-Cv). The development of CLO-NICR and CLO-NIC-Cv allows the integration of the cell lines from NICR into the community-based CLO ontology and provides an integrative platform to support different applications of CLO in China.
- 25 April 2019
- Published by Springer Nature in BMC Bioinformatics
- Vol. 20 (S5) , 249-258
Open AccessThe cell line ontology-based representation, integration and analysis of cell lines used in China
The Chinese National Infrastructure of Cell Line stores and distributes cell lines for biomedical research in China. This study aims to represent and integrate the information of NICR cell lines into the community-based Cell Line Ontology (CLO). We have aligned, represented, and added all identified 2704 cell line cells in NICR to CLO. We also proposed new ontology design patterns to represent the usage of cell line cells as disease models by inducing tumor formation in model organisms, and the relations between cell line cells and their expressed or overexpressed genes or proteins. The resulting CLO-NICR ontology also includes the Chinese representation of the NICR cell line information. CLO-NICR was merged into the general CLO. To serve the cell research community in China, the Chinese version of CLO-NICR was also generated and deposited in the OntoChina ontology repository. The usage of CLO-NICR was demonstrated by DL query and knowledge extraction. In summary, all identified cell lines from NICR are represented by the semantics framework of CLO and incorporated into CLO as a most recent update. We also generated a CLO-NICR and its Chinese view (CLO-NICR-Cv). The development of CLO-NICR and CLO-NIC-Cv allows the integration of the cell lines from NICR into the community-based CLO ontology and provides an integrative platform to support different applications of CLO in China.